Novo Nordisk's pricing procedures inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of value gouging, pointing out the stark distinction concerning U.S. rates and those in Europe and copyright.Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd,[3] w